1466674

N-Nitrosodimethylamine (NDMA)

United States Pharmacopeia (USP) Reference Standard

• 別名: N-Methyl-N-nitrosomethanamine, NDMA
• 実験式（ヒル表記法）: C₂H₆N₂O
• CAS番号: 62-75-9
• 分子量: 74.08
• MDL番号: MFCD00002053
• UNSPSCコード: 41116107
• NACRES: NA.24

特性

• 包装: pkg of 1 mg
• メーカー／製品名: USP
• アプリケーション: pharmaceutical (small molecules)
• フォーマット: single component solution (solution in methanol)
• 保管温度: −20°C
• SMILES記法: N(N=O)(C)C
• InChI: 1S/C2H6N2O/c1-4(2)3-5/h1-2H3
• InChI Key: UMFJAHHVKNCGLG-UHFFFAOYSA-N

詳細

詳細

This product is provided as delivered and specified by the USP Pharmacopoeia. For further information and support, including certificate/ product information sheets, please go to the website of the issuing Pharmacopoeia.

アプリケーション

N-Nitrosodimethylamine (NDMA) USP reference standard is intended for use only as specificallyprescribed in the United States Pharmacopoeia.

It is also used to prepare standard, standard stock, nitrosamine RS stock, nitrosamine standards stock solution mixture, and sensitivity stock solutions to determine NDMA impurity in drug substances and drug products(valsartan, irbesartan, and losartan potassium etc.) by chromatography method according to the general chapter 〈1469〉 of United States Pharmacopeia.

アナリシスノート

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  

その他情報

This product is part of USP Biologics Program.

Sales restrictions may apply.

安全性情報

• ピクトグラム: GHS02,GHS06,GHS08
• シグナルワード: Danger
• 危険有害性情報: H225,H301 + H311 + H331,H350,H370
• 注意書き: P201 - P210 - P280 - P301 + P310 - P303 + P361 + P353 - P304 + P340 + P311
• 危険有害性の分類: Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Carc. 1B - Flam. Liq. 2 - STOT SE 1
• ターゲットの組織: Eyes,Central nervous system
• 保管分類コード: 3 - Flammable liquids
• WGK: WGK 3
• 引火点(°F): 49.5 °F
• 引火点(℃): 9.7 °C